XASE
APUS
Oct 20, Last price
3.41USD
1D
-13.37%
1Q
-45.05%
IPO
-80.66%
Name
Apimeds Pharmaceuticals US Inc
Chart & performance
P/E
—
P/S
—
EPS
Vol. 1Y
192.07%
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
Net income
CFO
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Key people
Vin Menon
Chief Executive Officer · since 2025
Chief Financial Officer · since 2024
Erick Frim
Chief Financial Officer · since 2025
Erik Emerson
President · since 2025
Jakap Koo
Director · since 2023
Elona Kogan
Independent Director · since 2024
Carol O'Donnell
Independent Director · since 2023
Bennett Weintraub
Independent Director · since 2023
Valuation
No data to show